Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

New tool now available for studying neurotensin receptors

Sep. 9, 1998

Cortech to form new European company to develop PSI technology

Sep. 4, 1998

CAT demonstrates value of ProxiMol technology

Sep. 2, 1998

SNAP-8719: a valuable tool for studying alpha1D-adrenoceptor function

Sep. 2, 1998

GeneMedicine receives patent protection for gene delivery technologies

Sep. 1, 1998

Ciclosporin oral solution dispenser cleared by the FDA for marketing

Sep. 1, 1998

MorphoSys and LeukoSite enter collaboration agreement

Aug. 28, 1998

U.S. patent will issue for novel lipid-based gene delivery systems

Aug. 27, 1998

Anergen claims production methods for AnergiX compounds

Aug. 25, 1998

Phytera and Tsumura Juntendo expand research collaboration

Aug. 24, 1998

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...